In the News
PPD’s roles in COVID-19 work continue with milestones
PPD is partnering with various pharma companies to develop treatments and vaccines for the coronavirus.
PPD expands in China with new multifunctional clinical research lab in Suzhou
The new operation will offer bioanalytical, biomarker and vaccine sciences services for global and China-based biopharma customers.
PPD opens new clinical research lab in China
New multipurpose laboratory will support China-based biotech companies and Western pharmaceutical companies managing China research studies.
Growing the pharma base
From a one-person consulting firm to a global contract research organization, PPD has been at the forefront of the clinical research industry in the Cape Fear region.
Two PPD Leaders Earn Life Sciences Industry Recognition
Those recognized are Karen Kaucic, chief medical officer of PPD and president of Evidera -- a PPD business -- and Rhonda Henry, vice president of patient centered trials at PPD.
PPD collaborates with Lupus clinical research experts
Through the affiliation, the company can provide enhanced protocol and trial optimization capabilities for its customers.
THE IMPORTANCE OF PRINCIPAL INVESTIGATOR TRAINING
Many physicians and health care providers are intrigued by clinical research and seek out to become Principal investigators (PI) without knowing what that role entails.
Determining water content with a novel Karl Fischer titration approach
A team of PPD® Laboratories scientists discusses a new approach to testing water content in biologics to give a more accurate determination of actual water content in the biologic.
PPD pens Lupus Therapeutics pact to boost research for the autoimmune disease
Through the collaboration, PPD can provide enhanced protocol and trial optimization capabilities for its customers.